Literature DB >> 21556738

The evaluation of argyrophilic nucleolar organizing region proteins in fine-needle aspiration samples of thyroid.

Recep Eroz1, Nurhan Cucer, Zuleyha Karaca, Kursad Unluhizarci, Figen Ozturk.   

Abstract

Argyrophilic nucleolar organizing region associated proteins (AgNORs) have been shown to be of interest in a variety of different diseases including thyroid disorders. Our aim was to distinguish benign thyroid lesions from papillary thyroid carcinoma (PTC) via AgNOR count and with a new approach, via AgNOR surface area/total nuclear surface area (NORa/TNa) proportions in the nuclei on fine-needle aspiration (FNA) materials. Thirty patients (eight men and 22 women) whose FNA was compatible with benign lesion and 26 patients (eight men and 18 women) whose FNA was compatible with PTC were included in the study. Fine-needle aspiration materials were stained for AgNOR detection according to a specific protocol. One hundred nuclei per individual have been evaluated, and AgNOR number and NORa/TNa proportions of individual cells were measured and calculated by using a computer program. Patients with PTC had significantly (p<0.001) higher AgNOR count (4.6 ± 1.2%) than in the patients with benign lesions (2.0 ± 0.5%). Additionally, patients with PTC had significantly (p<0.001) higher NORa/TNa (13.4 ± 2.4) than in the patients with benign lesion (5.7 ± 1.0). Modified method of AgNOR staining is an easy and reliable method for evaluating proliferation activity of cells in malignant and benign thyroid lesions and it may contribute to routine cytopathology in inconclusive situations.

Entities:  

Mesh:

Year:  2011        PMID: 21556738     DOI: 10.1007/s12022-011-9161-z

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  25 in total

1.  Prognosis in mouth cancer: tumour factors.

Authors:  A S Jones
Journal:  Eur J Cancer B Oral Oncol       Date:  1994-01

2.  AgNOR quantification in the diagnosis of follicular pattern thyroid lesions.

Authors:  Dorota Słowińska-Klencka; Mariusz Klencki; Bozena Popowicz; Andrzej Lewiński
Journal:  Anal Quant Cytol Histol       Date:  2003-12       Impact factor: 0.302

Review 3.  Structural and functional organization of ribosomal genes within the mammalian cell nucleolus.

Authors:  Massimo Derenzini; Gianandrea Pasquinelli; Marie-Françoise O'Donohue; Dominique Ploton; Marc Thiry
Journal:  J Histochem Cytochem       Date:  2005-10-03       Impact factor: 2.479

4.  AgNOR measurements as indices of proliferation, ploidy and prognosis.

Authors:  J C Underwood
Journal:  Clin Mol Pathol       Date:  1995-10

5.  Nucleolar organizer regions in Spitz nevi and malignant melanomas.

Authors:  A J Howat; D D Giri; D W Cotton; D N Slater
Journal:  Cancer       Date:  1989-02-01       Impact factor: 6.860

6.  Higher NORs-expression in lymphocyte of trisomy 21 babies/children: in vivo evaluation.

Authors:  Nalan Imamoglu; Halil Demirtas; Hamiyet Donmez-Altuntas; Ali Ilten
Journal:  Micron       Date:  2005       Impact factor: 2.251

7.  AgNOR counts are useful in cervical smears.

Authors:  M R Cardillo
Journal:  Diagn Cytopathol       Date:  1992       Impact factor: 1.582

Review 8.  Prognostic relevance of cell proliferation in head and neck tumors.

Authors:  A Pich; L Chiusa; R Navone
Journal:  Ann Oncol       Date:  2004-09       Impact factor: 32.976

9.  The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status.

Authors:  M Derenzini; C Ceccarelli; D Santini; M Taffurelli; D Treré
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

Review 10.  Nuclear microenvironments in biological control and cancer.

Authors:  Sayyed K Zaidi; Daniel W Young; Amjad Javed; Jitesh Pratap; Martin Montecino; Andre van Wijnen; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  Nat Rev Cancer       Date:  2007-06       Impact factor: 60.716

View more
  1 in total

1.  Does capsaicin have therapeutic benefits in human colon adenocarcinoma? Selection of the most reliable dose via AgNOR

Authors:  Mustafa Nisari; Recep Eröz
Journal:  Turk J Med Sci       Date:  2020-06-23       Impact factor: 0.973

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.